Formation of anhydrosugars in the chemical depolymerization of heparin.
about
Expression of heparan sulfate D-glucosaminyl 3-O-sulfotransferase isoforms reveals novel substrate specificitiesHeparin-binding protein targeted to mitochondrial compartments protects endothelial cells from apoptosisUsing engineered 2-O-sulfotransferase to determine the activity of heparan sulfate C5-epimerase and its mutantsPrion, amyloid beta-derived Cu(II) ions, or free Zn(II) ions support S-nitroso-dependent autocleavage of glypican-1 heparan sulfateHeparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1The anti-angiogenic His/Pro-rich fragment of histidine-rich glycoprotein binds to endothelial cell heparan sulfate in a Zn2+-dependent mannerInfluence of collagen lattice on the metabolism of small proteoglycan II by cultured fibroblastsCharacterization of heparan sulphate 3-O-sulphotransferase isoform 6 and its role in assisting the entry of herpes simplex virus type 1Biosynthesis of dermatan sulphate. Assay and properties of the uronosyl C-5 epimeraseExpression of heparan sulphate L-iduronyl 2-O-sulphotransferase in human kidney 293 cells results in increased D-glucuronyl 2-O-sulphationHeparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectinsAnalysis and characterization of heparin impuritiesMolecular cloning and characterization of N-syndecan, a novel transmembrane heparan sulfate proteoglycanHeparan sulfate 6-O-endosulfatases: discrete in vivo activities and functional co-operativityQSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signalingMolecular cloning and expression of a third member of the heparan sulfate/heparin GlcNAc N-deacetylase/ N-sulfotransferase familyHeparan sulfate D-glucosaminyl 3-O-sulfotransferase-3A sulfates N-unsubstituted glucosamine residuesNeurite outgrowth in brain neurons induced by heparin-binding growth-associated molecule (HB-GAM) depends on the specific interaction of HB-GAM with heparan sulfate at the cell surfaceStructural analysis of the sulfotransferase (3-o-sulfotransferase isoform 3) involved in the biosynthesis of an entry receptor for herpes simplex virus 1Heparin/heparan sulfate biosynthesis: processive formation of N-sulfated domainsRepetitive Ser-Gly sequences enhance heparan sulfate assembly in proteoglycansChanges in glomerular heparan sulfate in puromycin aminonucleoside nephrosisCharacterization of the D-glucuronyl C5-epimerase involved in the biosynthesis of heparin and heparan sulfateThe occurrence of three isoforms of heparan sulfate 6-O-sulfotransferase having different specificities for hexuronic acid adjacent to the targeted N-sulfoglucosamineStimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypicanDermatan sulfate in tunicate phylogeny: order-specific sulfation pattern and the effect of [→4IdoA(2-sulfate)β-1→3GalNAc(4-sulfate)β-1→] motifs in dermatan sulfate on heparin cofactor II activityGlycomics approaches for the bioassay and structural analysis of heparin/heparan sulphatesSynthesis and distribution of glycosaminoglycans in human leukemic B- and T-cells and monocytes studied using specific enzymic treatments and high-performance liquid chromatography.Effects of mitogens on synthesis and distribution of heparan and chondroitin sulphates by human leukemic B, T cells and monocytes studied by high-performance liquid chromatography and radiochemical detection.Biosynthetic oligosaccharide libraries for identification of protein-binding heparan sulfate motifs. Exploring the structural diversity by screening for fibroblast growth factor (FGF)1 and FGF2 binding.Purification of a 75 kDa protein from the organelle matrix of human neutrophils and identification as N-acetylglucosamine-6-sulphatase.Oligosaccharide library-based assessment of heparan sulfate 6-O-sulfotransferase substrate specificity.Astroglial cells derived from lateral and medial midbrain sectors differ in their synthesis and secretion of sulfated glycosaminoglycans.3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3.Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures.Substrate specificity of 6-O-endosulfatase (Sulf-2) and its implications in synthesizing anticoagulant heparan sulfate.Chemoenzymatic synthesis of heparin oligosaccharides with both anti-factor Xa and anti-factor IIa activities.The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells.Synthesis of heparan sulfate with cyclophilin B-binding properties is determined by cell type-specific expression of sulfotransferases.
P2860
Q22001454-FC9B465A-EA13-4F8C-B776-19EF0C0848C6Q22010613-4819FF5E-D119-4883-BC83-3A5BC30AA39DQ24298022-83BA2CFE-4AB9-4292-BB01-ED514B7F5158Q24301330-AC47D4F4-C2FA-487C-8007-9027E2D871ABQ24302044-A392AC68-617F-40D4-A954-635AAF1BE6D4Q24302060-6691F562-F2F9-4406-B2E7-866DD0A34947Q24527364-1A2A326F-935E-4C66-9960-F7102709DB18Q24528151-C7FBA50E-9934-4ADE-AEA7-3C7BD652CCBAQ24531199-BCEB3B12-7AC7-4F52-B720-CC4DF1C8798CQ24531959-EDB8B2FE-6607-4CCB-BA8E-6A90F6BC20BDQ24552437-6603677B-86C1-4A3E-816F-7FC40F2D8856Q24605666-E37BA96C-016C-4ED2-A77A-171B5E0DD729Q24643493-1408CBE3-1AC1-4EC8-A419-06BCA0A8C78DQ24673740-C06CF0BF-93E8-4DF4-B847-4BE16115CEDDQ24675509-5F2AB351-E5E2-461E-8A98-542672C97D3EQ28118805-BDCF2667-1CA7-41A5-BF52-D100607FA07CQ28141121-29DF8ED2-25E0-4933-B158-503093866018Q28273686-2755A870-8208-4E57-B214-DD04422FFD0DQ28276530-1A982664-3519-4B63-8066-5D3BB9720FA1Q28280539-485B28F4-DE6C-4ADA-ABA6-3C3F0DEC2546Q28291974-0F60462D-6F03-41C8-9863-93FBE9E2F998Q28338256-A2B6E29A-F031-48FC-BC90-4939362881B7Q28590708-DC8A2640-8725-4ABC-B3C1-59EF2963C657Q28594700-9CA5C270-D1EB-4E24-B728-C80D5E021C03Q28633960-1681842E-EEC3-4A28-8824-75ADD932E2B2Q28743034-C9F436A0-08F4-4282-9942-1CF1F9FDC2A0Q30437948-5FACFB82-43A7-44F6-B89E-5CD137AC1B91Q30665086-569B7B5B-597E-4D4E-A9E2-1B22057F53CCQ30781026-89A32986-9FEA-43DE-A87F-158652B779EBQ31074211-345318F9-759E-4C62-8502-4EE19A0C7970Q31135804-1D4943E4-4E47-48F8-B66E-0CF701A8C4D2Q31139063-CA08A6AE-6777-4BD6-9768-631596DE790FQ31929329-3E7D2866-CCC6-4445-8145-D535DDA9C266Q33230192-DD74E97C-918F-469B-8434-692178CC5DE2Q33285352-14E76D44-258E-4104-9E10-8B1D0892A261Q33299802-00AE935E-61D9-4CA4-978C-65B716B4A4A0Q33401779-25F0321D-2097-4DE7-B698-245C0A92BDD8Q33402197-D46942D5-C428-46C2-8FE0-7CD3F9A149DAQ33467561-2551C1DB-F481-433C-99A2-E372FF90DC53Q33581865-C86EC07B-989A-4E12-96CF-E099F2A3B4DD
P2860
Formation of anhydrosugars in the chemical depolymerization of heparin.
description
1976 nî lūn-bûn
@nan
1976 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1976 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1976年の論文
@ja
1976年学术文章
@wuu
1976年学术文章
@zh-cn
1976年学术文章
@zh-hans
1976年学术文章
@zh-my
1976年学术文章
@zh-sg
1976年學術文章
@yue
name
Formation of anhydrosugars in the chemical depolymerization of heparin.
@ast
Formation of anhydrosugars in the chemical depolymerization of heparin.
@en
Formation of anhydrosugars in the chemical depolymerization of heparin.
@nl
type
label
Formation of anhydrosugars in the chemical depolymerization of heparin.
@ast
Formation of anhydrosugars in the chemical depolymerization of heparin.
@en
Formation of anhydrosugars in the chemical depolymerization of heparin.
@nl
prefLabel
Formation of anhydrosugars in the chemical depolymerization of heparin.
@ast
Formation of anhydrosugars in the chemical depolymerization of heparin.
@en
Formation of anhydrosugars in the chemical depolymerization of heparin.
@nl
P356
P1433
P1476
Formation of anhydrosugars in the chemical depolymerization of heparin.
@en
P2093
P304
P356
10.1021/BI00663A005
P407
P577
1976-09-01T00:00:00Z